Skip to Content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Health Highlights: Sept. 30, 2020

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: NYC Will Fine People Who Don't Wear Masks People in New...

Cancer Mortality Higher for U.S. Counties With Persistent Poverty

WEDNESDAY, Sept. 30, 2020 -- U.S. counties with persistent poverty (≥20 percent of residents in poverty since 1980) have higher rates of cancer mortality,...

Current Trends in COVID-19 Reported for U.S. Youth

WEDNESDAY, Sept. 30, 2020 -- The incidence of COVID-19 was higher in adolescents than among children during May to September 2020, according to research...

ECT May Reduce Suicide Risk in Patients With Bipolar Depression

WEDNESDAY, Sept. 30, 2020 -- Electroconvulsive therapy (ECT) may help treat features of bipolar depression, including suicidality, according to study results...

Pancreas Size, Shape Restored With Remission of T2DM

WEDNESDAY, Sept. 30, 2020 -- Pancreas size and shape can be restored with remission of type 2 diabetes, according to a study presented at the annual meeting of...

More U.S. Women Using Marijuana to Help Ease Menopause: Study

WEDNESDAY, Sept. 30, 2020 -- A growing number of middle-aged women are turning to marijuana to help soothe symptoms of menopause, new research...

No Race Difference Found in COVID-19 Mortality Rates at Same Medical Center

WEDNESDAY, Sept. 30, 2020 -- For admitted COVID-19 patients presenting to the same urban medical center, risk-adjusted outcomes were no worse for non-Hispanic...

AHA News: Despite Same Symptoms, Men and Women Don't Always Get Same Mini-Stroke Diagnosis

WEDNESDAY, Sept. 30, 2020 (American Heart Association News) -- A transient ischemic attack, often called a mini-stroke, usually doesn't last long or cause...

AHA News: Lung Injuries Should Be a Warning About Vaping's Risks

WEDNESDAY, Sept. 30, 2020 (American Heart Association News) -- The patients, most of them young, began showing up at hospitals in the spring of 2019. Some were...

What Foods, Medicines Can Lower Your Colon Cancer Risk?

WEDNESDAY, Sept. 30, 2020 -- Certain nutrients, foods and medicines may help protect you against colon cancer, a large research review suggests. A team of...

BridgeBio Pharma And Affiliate Origin Biosciences Announces FDA Acceptance Of Its New Drug Application For Fosdenopterin For The Treatment Of MoCD Type A

SAN FRANCISCO, September 29, 2020 – BridgeBio Pharma, Inc. (Nasdaq: BBIO) and affiliate Origin Biosciences today announced the US Food and Drug...

FDA Approves Bausch + Lomb Alaway Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035%

LAVAL, QC and DEER PARK, Ill., Sept. 25, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), Bausch + Lomb, a leading global...

U.S. FDA Approves Pfizer’s Xeljanz (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis

NEW YORK--(BUSINESS WIRE) September 28, 2020 -- Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA)...

FDA Approves Fetroja (cefiderocol) for the Treatment of Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia

OSAKA, Japan & FLORHAM PARK, N.J.--(BUSINESS WIRE) September 28, 2020 --Shionogi & Co., Ltd. (hereafter “Shionogi”) today announces that...

U.S. Food and Drug Administration Approves Haegarda (C1 Esterase Inhibitor Subcutaneous [Human]) for Prevention of Hereditary Angioedema (HAE) Attacks in Pediatric Patients

KING OF PRUSSIA, PA – September 28, 2020 – CSL Behring, a global biotherapeutics leader, announced today that the U.S. Food and Drug...

Aquestive Therapeutics Receives Complete Response Letter from FDA for Libervant (diazepam) Buccal Film for Management of Seizure Clusters

WARREN, N.J., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and...

FDA Approves Nucala (mepolizumab) as the First and Only Biologic Treatment for Hypereosinophilic Syndrome (HES)

London UK 25 September 2020 -- GlaxoSmithKline plc (GSK) today announced the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for the...

ADC Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for Loncastuximab Tesirine for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma

LAUSANNE, Switzerland--(BUSINESS WIRE)-- September 24, 2020 -- ADC Therapeutics SA (NYSE: ADCT), a late clinical-stage oncology-focused biotechnology company...

U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb and bluebird bio Application for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel (Ide-cel, bb2121)

PRINCETON, N.J., & CAMBRIDGE, Mass.--(BUSINESS WIRE) September 22, 2020 -- Bristol Myers Squibb (NYSE: BMY) and bluebird bio, Inc. (Nasdaq: BLUE) today...

Orphazyme Announces FDA Acceptance and Priority Review of New Drug Application for Arimoclomol for Niemann-Pick Disease Type C

Copenhagen, Denmark, September 16, 2020 – Orphazyme A/S (ORPHA.CO), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for...

CTI BioPharma to Submit a New Drug Application (NDA) for the Accelerated Approval of Pacritinib for the Treatment of Myelofibrosis Patients with Severe Thrombocytopenia

SEATTLE, Sept. 29, 2020 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced that following a recent Pre-NDA meeting with the U.S. Food and Drug...

Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Older Adult Age Cohorts in Phase 1 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 29, 2020-- Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and...

INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800

PLYMOUTH MEETING, Pa., Sept. 28, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA...

Khondrion Receives Rare Pediatric Disease Designation for Sonlicromanol from US FDA

September 28, 2020 -- Khondrion, a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease, today...

Johnson & Johnson Posts Interim Results from Phase 1/2a Clinical Trial of its Janssen COVID-19 Vaccine Candidate

September 25, 2020 -- Interim analysis from the ongoing Phase 1/2a clinical trial of the Janssen COVID-19 vaccine candidate (JNJ-78436735) was posted today on...

Older Articles by News Type

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.